Skip to main content

Publications from the Nanotechnology Characterization Lab

Recent Publications 

Cancer nanomedicine.
Bhatia SN, Chen X, Dobrovolskaia MA,Lammers T.
Nature Reviews Cancer. 2022. [PubMed Abstract]

Locking and unlocking thrombin function using immunoquiescent nucleic acid nanoparticles with regulated retention in vivo.
Ke W, Chandler M, Cedrone E, Saito RF, Rangel MC, de Souza Junqueira M, Wang J, Shi D, Truong N, Richardson M, Rolband LA, Dreau D, Bedocs P, Chammas R, Dokholyan NV, Dobrovolskaia MA, Afonin KA.
Nano Letters. 2022; 22(14): 5961-5972. [PubMed Abstract]

The future of tissue-targeted lipid nanoparticle-mediated nucleic acid delivery.
Kularatne RN, Crist RM, Stern ST.
Pharmaceuticals. 2022; 15(7): 897. [PubMed Abstract]

Immunophenotyping: analytical approaches and role in preclinical development of nanomedicines.
Newton HS, Dobrovolskaia MA.
Adv Drug Deliv Rev. 2022; 185: 114281. [PubMed Abstract]

Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines.
Szebeni J, Storm G, Ljubimova JY, Castells M, Phillips EJ, Turjeman K, Barenholz Y, Crommelin DJA, Dobrovolskaia MA.
Nat Nanotechnol. 2022; 17(4): 337-346. [PubMed Abstract]

Anhydrous nucleic acid nanoparticles for storage and handling at broad range of temperatures.
Tran AN, Chandler M, Halman J, Beasock D, Fessler A, McKeough RQ, Lam PA, Furr DP, Wang J, Cedrone E, Dobrovolskaia MA, Dokholyan NV, Trammell SR, Afonin KA.
Small. 2022; 18(13): e2104814. [PubMed Abstract]

To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.
Shi D, Beasock D, Fessler A, Szebeni J, Ljubimova JY, Afonin KA, Dobrovolskaia MA.
Adv Drug Deliv Rev. 2022; 180: 114079. [PubMed Abstract]

Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.
Afonin KA, Dobrovolskaia MA, Ke W, Grodzinski P, Bathe M.
Adv Drug Deliv Rev. 2022; 181: 114081. [PubMed Abstract]


For a more comprehensive list of NCL publications, visit our Web of Science bibliography page.


  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Publications from the Nanotechnology Characterization Lab was originally published by the National Cancer Institute.”